Dr Maria Tsoli is a 2019 Cure Brain Cancer Foundation Innovation Grant recipient.
Thanks to new funding from Cure Brain Cancer Foundation, five of Australia’s most innovative and promising brain cancer researchers will receive $1.14m to allow them to focus on projects aimed solely at rapidly improving brain cancer survival.
This significant investment by Cure Brain Cancer Foundation is comprised of Innovation Grants, which encourage high-calibre researchers to pursue novel ideas, outside of usual government funding models, and Early Career Fellowships, which ensure Australia’s brightest researchers devote their brilliant young minds to curing brain cancer.
Brain cancer survival has barely improved in more than 30 years, making Cure Brain Cancer Foundation’s commitment to fund novel and “outside-the-box” research more crucial than ever.
Each project was rigorously reviewed and approved by the Foundation’s world-class independent Scientific Advisory Committee following a competitive application process. The calibre of this year’s applicants was so high that the Foundation has doubled the number of Innovation Grants awarded this year compared to last.
Cure Brain Cancer
Foundation CEO, Associate Professor Kerrie McDonald said, “Each new grant announced today greatly increases the likelihood of more desperately needed breakthroughs. I sincerely believe these brilliant researchers and their truly innovative work will move us closer to a cure for brain cancer – a disease that kills more Australian children than any other, and more people under 40 than any other cancer.”
Cure Brain Cancer Foundation’s four 2019 Innovation Grant recipients will each receive $200,000 per project, over two years. They are:
Andrew Morokoff, Royal Melbourne Hospital and University of Melbourne
A blood test for glioma diagnosis and monitoring
Misty Jenkins, The Walter and Eliza Hall Institute of Medical Research
Using the power of the immune system to treat glioblastoma
Dr Maria Tsoli, Children’s Cancer Institute
New ways to get drugs into the brainstem and treat DIPG
Helen Rizos, Macquarie University
Making brain tumours more receptive to immunotherapy.
Han Shen (PhD) is Cure Brain Cancer Foundation's 2019 Early Career Fellow.
Meanwhile, the Early Career Fellowship recipient
will receive $115,000 per year over three years:
Han Shen (PhD), Westmead Institute for Medical Research
Improving the radio-sensitivity of diffuse intrinsic pontine gliomas (DIPG) by targeting hypoxia and sugar metabolism.
These grants will greatly increase Australia’s brain cancer research capacity and ensure our best and brightest researchers are working in the field of brain cancer.
This funding announcement takes Cure Brain Cancer Foundation’s research investment over the last five years to more than $19 million. This has only been possible thanks to the generosity of our many donors, philanthropists, and partners.
Help fund more ground-breaking researchers